Centro Nacional de Investigaciones Cardiovasculares Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2020

  1. Identification of Senior At Risk scale predicts 30-day mortality among older patients with acute heart failure

    Medicina Intensiva, Vol. 44, Núm. 1, pp. 9-17

  2. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

    Journal of the American College of Cardiology, Vol. 75, Núm. 15, pp. 1772-1784

2019

  1. Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort

    European Journal of Heart Failure, Vol. 21, Núm. 10, pp. 1231-1244

  2. Psychiatric Symptoms and Sex-related Differences in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries

    Revista Espanola de Cardiologia, Vol. 72, Núm. 8, pp. 686-688

2015

  1. Diagnostic accuracy of coronary ct for the quantification of the syntax score in patients with left main and/or 3-vessel coronary disease. Comparison with invasive angiography

    International Journal of Cardiology, Vol. 182, pp. 549-556

1994

  1. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: Evidence for an autoparacrine regulatory system

    Endocrinology, Vol. 135, Núm. 6, pp. 2526-2532